Выпуск

DermaSensor CEO Cody Simmons on Putting Skin Cancer Detection in the Primary Care Office

Inside Startup Investing with Chris Lustrino · 5 ноября 2026 г. · 30 мин

Cody Simmons had his first skin biopsy at 15, and his mom and aunt both had early-stage melanoma. Today he is the co-founder and CEO of DermaSensor, a Miami company whose FDA-cleared handheld device lets a primary care doctor scan a suspicious mole and get a second opinion in about two minutes — instead of sending the patient to a dermatologist with a copay, hours off work and, in much of the country, a wait of months.   Cody joins Chris Lustrino to walk through the business from the beginning: the 2016 call from Dr. Maurice Ferré (Mako Surgical) to turn a Boston University research project into a company; the three years spent shrinking a microwave-sized machine into a handheld; four years of clinical studies, including a 1,000-patient pivotal trial across 22 sites; and FDA clearance under the De Novo pathway. DermaSensor has now been commercial for a little over two years, growing revenue about 30% quarter over quarter, and has just signed four national channel partners, including Henry Schein and a health system that employs tens of thousands of providers.   Then Cody does something few medical-device founders can do on a podcast: he scans a mole on his own forearm, live, and talks through what the doctor sees, what the device reports, and what that two-minute result replaces.   In this episode: ●      How a distributor relationship actually works — long lead times, "order takers," SPIFs and conference pitches ●      Why a contract sales force like MTMC matters alongside a catalog distributor like Henry Schein ●      The ABCDEs of melanoma, and why a family doctor isn't trained to read them like a dermatologist ●      What the pivotal study showed when the device went head to head with primary care physicians ●      Billing today under an unlisted CPT code, and the Category I code the company plans to apply for ●      The $199 / $399-a-month rental model, and why pricing is kept consistent across channels ●      The best-fit customer: doctors who want to manage skin conditions themselves — and the ones who pass ●      What success looks like two to three years out   Guest: Cody Simmons, Co-Founder & CEO, DermaSensor Host: Chris Lustrino, Founder & CEO, Kingscrowd   DermaSensor is raising now. Kingscrowd rates DermaSensor a 4.1 out of 5. To see the full analyst breakdown and discover how you can invest, visit kingscrowd.com.   Inside Startup Investing is the only podcast where you can invest in every guest. Subscribe so you never miss a founder interview.   Disclosure: This episode is for informational purposes only and is not investment advice or a recommendation to buy any security. Investing in early-stage companies is risky and illiquid, and you may lose your entire investment.

Страница выпуска